Steven Crowley, CFA
	(612) 334-6304 steve.crowley@craig-hallum.com Senior Research Analyst Associate Analyst - Matthew Hewitt (612) 334-6314 matthew.hewitt@craig-hallum.com

Steve Crowley is a Managing Director and Senior Research Analyst in the Equity Research Department at Craig-Hallum Capital Group LLC, where he covers various medical technology companies and is responsible for the firm's Health Care Research practice.  Previously, he spent 11 years at Kopp Investment Advisors as a Senior Portfolio Manager for the firm’s Emerging Growth and Total Quality Management investment strategies.  He started in the investment business in 1985 as an analyst with Market Guide, Inc., followed by stints on both the buy-side (J.P. Morgan Investment Management) and sell-side (Craig-Hallum, Inc. & Summit Capital Group) before joining Kopp in 1994.  Mr. Crowley holds a B.A. in Economics from the University of Chicago.  He is a CFA charterholder.

 

Research Coverage

- Haemonetics Corporation (HAE)

- IRIS International (IRIS)

- Neogen (NEOG)

- NVE Corporation (NVEC)

- Omnicell (OMCL)

- Quidel Corporation (QDEL)

- Techne (TECH)

- Vital Images (VTAL)

Alpha Select List

* Akorn (AKRX)

* MedTox Scientific (MTOX)

Interest List

* Meridian Bioscience (VIVO)

* Trinity Biotech (TRIB)

* Uroplasty (UPI)

< Back